M

Myovant Sciences

597 employees

Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men.

Basic info

Industry

biotechnology research

Sectors

Men's
Biotechnology
Women's
Life Science
Health Care

Date founded

2016

Funding rounds raised

Total raised

$200M

from 3 investors over 3 rounds

M

Myovant Sciences raised $200M on August 5, 2020

Investors: Dainippon Sumitomo Pharma

M

Myovant Sciences raised $100M on October 16, 2017

Investors: -

M

Myovant Sciences raised $40M on October 16, 2017

Investors: Hercules Capital, Inc.

FAQ